Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trialP. Comella, G. Comella, G.P. Nicolella et al.|European Journal of Cancer|1999Cited by 3